Home › Services
Umbrella Pharma develops and manufactures small-molecule therapeutics under licence for partner organisations and for the group's own portfolio. Our Dublin facility covers the full route from process development through to packaged commercial supply, with analytical laboratory capability on the same site.
The division's core programmes are concentrated in anti-viral therapeutics and regenerative treatment research. These are long-horizon programmes; several have been running continuously since the early 2000s. We accept that this is an unusual commitment profile, and it is one of the reasons partners work with us on compounds that larger contract manufacturers decline.
All manufacturing operations are conducted under Good Manufacturing Practice, with batch records, stability programmes and deviation management handled in-house. We support technology transfer both inbound and outbound, and we retain manufacturing documentation for the full regulatory retention period of each product.
Umbrella Chemical GmbH operates the group's speciality and fine chemical production from its site in the Frankfurt industrial park. The plant produces intermediates, reagents and formulated products for industrial, agricultural and laboratory customers, with an emphasis on low-volume, high-specification batches.
The Frankfurt operation is built around flexibility. Reactor capacity is configured so that campaigns can be changed over within days rather than weeks, which allows us to serve customers whose annual requirement is measured in hundreds of kilograms rather than tonnes. Where a customer's specification falls outside standard catalogue chemistry, our process team will develop a route and validate it before quotation.
Chemical safety, transport classification and waste handling are managed under German and European regulation. Safety data sheets are maintained for every product in the catalogue and are reissued on any change to classification or composition.
Umbrella Health Services provides clinical and occupational health programmes to corporate and institutional clients from its London base. The division was established in 2009, initially to serve the group's own workforce, and now operates as a standalone service business with external contracts across the United Kingdom.
Programmes include pre-placement and periodic health assessment, exposure monitoring for clients operating in industrial environments, vaccination and travel health services, and diagnostic support delivered either on the client's premises or at our London clinic. Reporting is structured so that employers receive the fitness information they require while individual clinical detail remains confidential to the examining clinician.
The division also supports the group's own sites. Exposure monitoring at the Frankfurt plant and the Dublin laboratory is administered by Umbrella Health under the same protocols applied to external industrial clients.
How engagements usually start.
An initial technical discussion to establish scope, volumes and regulatory context. Non-disclosure agreements are signed before any specification is shared.
Our process and quality teams assess the requirement against existing capability and issue a written feasibility position, including any development work required.
Following qualification batches and documentation review, the programme moves to scheduled supply under a long-term agreement.